Product Liability

  • April 14, 2026

    Keurig Accused Of Falsely Labeling K-Cups Recyclable

    Keurig Dr Pepper Inc. is facing a proposed class action alleging it violated New York consumer protection statutes by deceptively labeling its popular K-Cup pods as recyclable.

  • April 14, 2026

    Tesla Drivers Urge 9th Circ. To Preserve False Ad Class

    California drivers have told the Ninth Circuit that they've offered sufficient evidence of Tesla's pervasive and misleading advertising to forge ahead with their certified class claims alleging Tesla deceived consumers into believing that its cars could fully drive themselves.

  • April 14, 2026

    Parts Co.'s Suit Says Chrysler Drivers Can't Link It To Fraud

    The manufacturer of seat height adjusters in Chrysler and Dodge vehicles has said it never directly sold defective products to Texas drivers bringing fraud claims in a federal proposed class action alleging the producer concealed a defect alongside the carmaker.

  • April 14, 2026

    Buyers Seek Final Approval Of $4.85M Bayer Benzene Deal

    A class of consumers is asking a New Jersey federal court to give final approval of a $4.85 million settlement to resolve claims that Bayer US LLC's antifungal products were contaminated with benzene.

  • April 14, 2026

    State AGs, Albertsons Chain Reach $773M Opioid Deal

    Albertsons Cos. Inc. and the attorneys general of California, Colorado, Illinois and Oregon on Tuesday said that the pharmacy and grocery chain had agreed to a $773 million settlement in principle to end claims brought by states, local governments and Native American tribes over its role in the opioid crisis.

  • April 14, 2026

    Berkshire Hathaway Unit Gets Some Claims Limited In RV Suit

    A Montana federal judge agreed to limit the scope of some class claims in a suit against a Berkshire Hathaway-owned RV maker, finding some claims are subject to the statute of limitations, while others can be tolled by the discovery rule.

  • April 14, 2026

    Vehicle Co. Inks $150K Deal To End Tobacco Fee Suit

    International Motors LLC, formerly Navistar, has agreed to pay $150,000 to resolve a suit claiming the company illegally charged workers an extra $600 a year if they used tobacco without giving them a proper avenue to dodge the fee, according to an Illinois federal court filing.

  • April 13, 2026

    Jury Chosen In Small Biz Suit Against 3M For Texas Explosion

    A Texas jury was impaneled Monday for the third bellwether trial in multidistrict litigation in a 2020 Houston disaster where an industrial explosion killed three people, setting the stage for opening statements over whether 3M Co. should be liable for damage.

  • April 13, 2026

    OpenAI State Murder-Suicide Case Doesn't Ax Federal Suit

    The estate of a man who it claims was driven by ChatGPT to murder his mother and commit suicide can proceed with its federal suit against OpenAI, a California judge ruled Monday, saying there's "substantial doubt" that a state court case brought by the mother's estate would resolve the federal action's claims.

  • April 13, 2026

    Exxon Can't Halt Heat Death Suit Ahead Of Climate Tort Ruling

    A Washington state court judge has denied an attempt by Exxon and other major oil and gas producers to pause a first-of-its-kind lawsuit over a 2021 Seattle heat wave death until the U.S. Supreme Court decides on the viability of climate torts in a Colorado case.

  • April 13, 2026

    Insurer Says Coverage Barred For Alleged Nitrous Oxide Sales

    Admiral Insurance Co. has no duty to defend or indemnify a group of smoke shops from claims they illegally sold nitrous oxide canisters to individuals, allegedly resulting in several fatal car accidents, the insurer told a Michigan federal court.

  • April 13, 2026

    Hyundai Eyes Exit In Insurer Car-Theft Bellwether Trial

    Hyundai Motor America has asked a California federal judge to wipe out State Automobile Mutual Insurance Co.'s claims ahead of a bellwether trial next month seeking to hold the automaker liable for allegedly selling theft-prone vehicles that heightened the risk of insurance claims.

  • April 13, 2026

    FTC Ends Teen Height Growth Supplement Claims

    A supplement maker and its owners agreed to pay $750,000 to end claims they misled customers into thinking their products could make their children taller, the Federal Trade Commission announced on Monday.

  • April 13, 2026

    State Meta Verdicts May Offer Clues For 1st Federal Bellwether

    Meta's recent state jury losses in suits over social media's harms to mental health provide clues as to what will happen this summer when a school district's suit against social platforms goes to trial in the first federal bellwether — and down the road in appeals some believe will reach the nation's high court.

  • April 13, 2026

    Del. Judge Ends 80K Pre-2026 Zantac Cases

    A Delaware state court on Monday dismissed more than 80,000 suits filed before December alleging that Boehringer Ingelheim's discontinued heartburn medication Zantac caused cancer, following a Delaware Supreme Court ruling on admissibility of the plaintiffs' experts.

  • April 13, 2026

    Texas AG Says Lululemon Clothes Have 'Forever Chemicals'

    The Texas attorney general on Monday accused Lululemon USA Inc. of selling activewear tainted with so-called forever chemicals, announcing that his office will investigate the company for allegedly misleading Texas consumers.

  • April 13, 2026

    PacifiCorp Damages Tab Rises With Liability Uncertain

    An Oregon jury on Monday ordered PacifiCorp to pay $14.5 million to a group of 11 survivors of 2020 fires, although the validity of the damages-only verdict is uncertain after an appeals court days ago overturned the liability verdict underlying it.

  • April 13, 2026

    Mars Says Peanut M&M Labeling Sinks Allergy Lawsuit

    Mars Inc. is urging a Connecticut state court to throw out a suit from a woman alleging that she had an allergic reaction after eating M&M's Minis, saying her revised complaint's admission that she bought Peanut Butter M&M's Minis dooms any claims she has for negligence.

  • April 13, 2026

    Coors Says Botched Sulfuric Acid Delivery Led To $2M Damage

    Molson Coors says its Colorado chemical contractor accepted and delivered a shipment of sulfuric acid that was nearly double what the beverage giant had ordered, causing a tank overflow that forced a full plant evacuation and caused $2 million in damages, according to a new lawsuit filed in Colorado state court.

  • April 13, 2026

    Texas GLP-1 Compounder Caused Mom's Death, Family Says

    A Houston compounding pharmacy misled consumers by marketing its weight loss and diabetes drugs as safe and pharmaceutical-grade while selling contaminated medicines, a deceased Texas woman's family claims in a wrongful death lawsuit, alleging the drugs led to the woman's death. 

  • April 13, 2026

    Costco Says Its Food Prep Eliminates All Chicken Concerns

    Costco has told a Washington federal judge that its popular rotisserie chickens pose no health risk to customers because the product is fully cooked, in a bid to dismiss a proposed class action claiming the product is processed in a plant contaminated with salmonella.

  • April 13, 2026

    Uber Says Driver Deactivation Not Proof Of Sex Assault

    On the eve of jury selection in a bellwether trial in multidistrict litigation against Uber over alleged sexual assaults, the ride-share company is asking a North Carolina federal court to exclude an offer of proof purporting to cast a driver's deactivation as an admission from Uber that an alleged sexual assault occurred.

  • April 13, 2026

    Abbott Urges Toss Of Relator, State Suits In FCA Recall Row

    Abbott Laboratories urged a Michigan federal court to throw out litigation brought by whistleblowers and a group of states over the 2022 infant formula shortage, saying their respective complaints lacked the details necessary to support claims that it defrauded numerous healthcare programs.

  • April 13, 2026

    Meta Pulls Some Attys' Social Media Addiction Ads

    After losing a bellwether trial last month in one of a slew of cases from plaintiffs who claim to have been harmed by social media, Meta has begun removing ads from attorneys seeking clients with similar claims.

  • April 13, 2026

    NC High Court Snapshot: State Retirees Fight To Retain Class

    The North Carolina Supreme Court in April will tackle a long-simmering fight over the state's obligations to provide health insurance to retired public employees, who are battling to keep their class status.

Expert Analysis

  • 4 Quick Emotional Resets For Lawyers With Conflict Fatigue

    Author Photo

    Though the emotional wear and tear of legal work can trap attorneys in conflict fatigue — leaving them unable to shake off tense interactions or return to a calm baseline — simple therapeutic techniques for resetting the nervous system can help break the cycle, says Chantel Cohen at CWC Coaching & Therapy.

  • Rescheduling Cannabis Marks New Tax Era For Operators

    Author Photo

    As the attorney general takes steps to move cannabis from Schedule I to Schedule III of the Controlled Substances Act, operators and advisers should prepare by considering the significant changes this will bring from tax, state, industry and market perspectives, says Michael Harlow at CohnReznick.

  • Series

    Playing Tennis Makes Me A Better Lawyer

    Author Photo

    An instinct to turn pain into purpose meant frequent trips to the tennis court, where learning to move ahead one point at a time was a lesson that also applied to the steep learning curve of patent prosecution law, says Daniel Henry at Marshall Gerstein.

  • False Ad Suit Shows Need For Clear, Conspicuous Disclosure

    Author Photo

    The Eleventh Circuit's recent false advertising decision in Federal Trade Commission v. Corpay reiterated the FTC's guidance imploring advertisers to ensure that any disclosures are clear and conspicuous to consumers, providing companies with numerous lessons about truthful advertising and highlighting some common disclosure pitfalls to avoid, says Michael Justus at Carlton Fields.

  • How Generative AI Cos. Can Navigate Product Liability Claims

    Author Photo

    Increasingly, plaintiffs are aggregating disputes over generative artificial intelligence and pursuing them through mass-tort-style proceedings, borrowing tactics from litigation involving social media, pharmaceuticals and other consumer-facing products — but there are approaches that AI companies can use to narrow claims and manage long-term exposure, say attorneys at Arnold & Porter.

  • And Now A Word From The Panel: MDL Year In Review

    Author Photo

    2025 was a roller coaster for the Judicial Panel on Multidistrict Litigation, with the panel canceling one hearing session due to the absence of new MDL petitions, yet also issuing rulings on more new MDL petitions than in 2024 — making it clear that MDLs are still thriving, says Alan Rothman at Sidley Austin.

  • Class Actions At The Circuit Courts: January Lessons

    Author Photo

    In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses five rulings from October and November, and identifies practice tips from cases involving consumer fraud, oil and gas leases, toxic torts, and wage and hour issues.

  • Series

    Judges On AI: How Judicial Use Informs Guardrails

    Author Photo

    U.S. Magistrate Judge Maritza Dominguez Braswell at the U.S. District Court for the District of Colorado discusses why having a sense of how generative AI tools behave, where they add value, where they introduce risk and how they are reshaping the practice of law is key for today's judges.

  • What US Cos. Must Know To Comply With Italy's AI Law

    Author Photo

    Italy's newly effective artificial intelligence law means U.S. companies operating in Italy or serving Italian customers must now meet EU AI Act obligations as well as Italy-specific requirements, including immediately enforceable criminal penalties, designated national authorities and sector-specific mandates, say attorneys at Portolano Cavallo.

  • Navigating Battery Validation Risk In The EV Supply Chain

    Author Photo

    Vehicle electrification has moved battery system supply chains from a background component into the center of the automotive universe — and for legal teams, battery validation is now a driver of contractual disputes, regulatory exposure and even shareholder litigation, say Samuel Madden at Secretariat Advisors and Vanessa Miller at Foley & Lardner.

  • Series

    Adapting To Private Practice: 5 Tips From Ex-SEC Unit Chief

    Author Photo

    My move to private practice has reaffirmed my belief in the value of adaptability, collaboration and strategic thinking — qualities that are essential not only for successful client outcomes, but also for sustained professional satisfaction, says Dabney O’Riordan at Fried Frank.

  • Series

    Law School's Missed Lessons: How To Start A Law Firm

    Author Photo

    Launching and sustaining a law firm requires skills most law schools don't teach, but every lawyer should understand a few core principles that can make the leap calculated rather than reckless, says Sam Katz at Athlaw.

  • Key False Claims Act Trends From The Last Year

    Author Photo

    The False Claims Act remains a powerful enforcement tool after some record verdicts and settlements in 2025, and while traditional fraud areas remain a priority, new initiatives are raising questions about its expanding application, says Veronica Nannis at Joseph Greenwald.

  • Reel Justice: 'Die My Love' And The Power Of Visuals At Trial

    Author Photo

    The powerful use of imagery to capture the protagonist’s experience of postpartum depression in “Die My Love” reminds attorneys that visuals at trial can persuade jurors more than words alone, so they should strategically wield a new federal evidence rule allowing for illustrative aids, says Veronica Finkelstein at Wilmington University.

  • Opinion

    It's Too Soon To Remove Suicide Warnings From GLP-1 Drugs

    Author Photo

    The U.S. Food and Drug Administration's decision this month to order removal of warnings about the risk of suicidal thoughts from GLP-1 weight-loss drugs is premature — and from a safety and legal standpoint, the downside of acting too soon could be profound, says Sean Domnick at Rafferty Domnick.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Product Liability archive.